Ulcerative Colitis Management

Introduction

If you have been diagnosed with ulcerative colitis, you are probably trying to understand what comes next. The condition can feel unpredictable — quiet for months and then suddenly active again — and the language around it (flares, remission, biologics, mucosal healing) can be confusing. This guide explains how ulcerative colitis is managed over the long term, what your gastroenterology team is trying to achieve at each stage, and how daily life fits around the condition.

Ulcerative colitis (often shortened to UC) is a form of inflammatory bowel disease (IBD) that causes ongoing inflammation and ulcers in the inner lining of the large intestine (the colon and rectum). It is different from irritable bowel syndrome (IBS), which does not cause inflammation, and different from Crohn’s disease, the other major form of IBD, which can affect any part of the digestive tract.

There is no medication that cures ulcerative colitis, but the treatments available today are very different from what existed even ten or fifteen years ago. With the right combination of medication, monitoring and lifestyle adjustments, most people with UC can reach and stay in remission for long periods, and many lead full, active lives.

What Is Ulcerative Colitis?

Ulcerative colitis is a chronic immune-mediated disease. The body’s own immune system — the system that normally protects against infection — reacts against the lining of the colon, causing redness, swelling, small ulcers, and bleeding. Unlike Crohn’s disease, the inflammation in UC is limited to the colon and rectum and usually affects only the innermost layer of the bowel wall.

The inflammation almost always starts in the rectum (the last part of the large bowel) and extends upward continuously, without skipping areas. How far up the colon it spreads varies from person to person and is one of the things doctors describe when they classify the disease.

Disease extent

Doctors usually describe UC by how much of the colon is involved:

• Proctitis — inflammation limited to the rectum.
• Proctosigmoiditis or left-sided colitis — inflammation extends from the rectum into the lower (left) part of the colon.
• Extensive colitis or pancolitis — inflammation involves most or all of the colon.

Disease activity: flare and remission

Ulcerative colitis follows a relapsing-remitting course. A flare is a period of active inflammation with symptoms such as diarrhoea, blood in stool, urgency and cramping. Remission is a period when symptoms settle and the bowel lining begins to heal. The aim of management is not just to make symptoms better in the moment but to keep the disease in remission and to heal the bowel lining underneath — what doctors call mucosal healing.

Causes and Risk Factors

The exact cause of ulcerative colitis is not fully understood. Current thinking is that UC develops when several factors come together: an inherited tendency for the immune system to react in a certain way, the bacteria that normally live in the gut, and environmental triggers that tip the balance. It is not caused by anything you ate, anything you did, or by stress alone.

Factors that contribute

• Immune system response — the immune system reacts to the bacteria normally present in the colon as if they were harmful, producing chronic inflammation.
• Genetics — having a close relative with IBD increases the chance of developing the condition, although most people with UC have no family history.
• Gut microbiome — the balance of bacteria in the bowel appears to be different in people with UC, though it is not clear whether this is a cause or a consequence.
• Environmental triggers — certain infections, antibiotic use early in life, and other environmental factors have been linked with higher risk in research studies.

Known patterns

• UC is most often diagnosed between the ages of 15 and 35, but it can begin at any age, including in children and in older adults.
• It is more common in urban populations and in higher-income countries, and rates in India and other parts of South Asia have been rising in recent decades.
• Interestingly, current and former smokers have a lower risk of UC than non-smokers — the opposite of the pattern seen in Crohn’s. This is not a reason to smoke; the overall harms of smoking far outweigh this effect.

Recognising a Flare

If you already have a diagnosis of ulcerative colitis, recognising a flare early matters more than recognising the disease for the first time. Treating a flare quickly often means a milder course and fewer days lost to the illness.

Typical flare symptoms

• Diarrhoea, often with blood or mucus
• Urgency — a sudden, hard-to-control need to pass stool
• Tenesmus — the feeling of needing to pass stool even when the bowel is empty
• Lower abdominal cramping, often relieved briefly after a bowel motion
• Waking at night to pass stool
• Tiredness that is out of proportion to your activity

Signs that a flare may be severe

Some flares are more serious and need urgent medical attention rather than waiting for a routine appointment. Warning signs include:

• More than six bloody stools a day
• Fever
• A rapid heartbeat
• Significant abdominal pain or swelling of the abdomen
• Light-headedness or fainting
• Inability to keep fluids down

These features can point to a severe flare that may need hospital treatment, including intravenous medication. Contact your gastroenterology team or go to an emergency department if these appear.

Symptoms outside the bowel

UC can cause symptoms outside the gut in some people. These extra-intestinal manifestations may include joint pain, mouth ulcers, painful red skin nodules, eye inflammation (uveitis or episcleritis), and a liver condition called primary sclerosing cholangitis. Mention any of these symptoms to your gastroenterologist, as some of them can flare independently of the bowel.

Diagnosis and Disease Assessment

If you are reading this with a diagnosis already in place, your team has likely used several of the tests below. They will continue to be used through your care to assess how the disease is behaving over time.

Tests used to diagnose and monitor UC

• Blood tests — checking for anaemia, inflammation markers (such as CRP), liver and kidney function, and nutritional status.
• Stool tests — ruling out infections that can mimic or trigger flares, and measuring faecal calprotectin, a protein that rises when there is inflammation in the bowel. Calprotectin is increasingly used to track disease activity without repeated colonoscopies.
• Colonoscopy with biopsy — the main test for diagnosis and for periodically reassessing how much of the colon is involved and how active the inflammation is. Small tissue samples (biopsies) confirm the diagnosis and rule out other causes.
• Flexible sigmoidoscopy — a shorter version of colonoscopy that examines just the lower part of the colon. It is often used during severe flares when a full colonoscopy would be too risky.
• Imaging — CT or MRI scans are sometimes used to assess complications such as severe inflammation, narrowing, or to distinguish UC from Crohn’s disease.

Severity scoring

Doctors use scoring systems — for example the Mayo score or the Truelove and Witts criteria — to classify a flare as mild, moderate or severe. This influences whether you can be managed at home with oral and rectal medication, or whether hospital admission and intravenous treatment are needed.

Treatment and Management

Ulcerative colitis treatment has two phases. The first is induction of remission — calming an active flare. The second is maintenance of remission — keeping the disease quiet over the long term. Major society guidelines from the American College of Gastroenterology (ACG), the American Gastroenterological Association (AGA), the European Crohn’s and Colitis Organisation (ECCO) and the British Society of Gastroenterology (BSG) describe a step-up approach in which the strength of treatment is matched to the severity and extent of disease, and adjusted based on response.

Aminosalicylates (5-ASA medicines)

5-ASA medicines, including mesalazine (mesalamine) and sulfasalazine, work directly on the lining of the colon to reduce inflammation. They come in tablet form and also as rectal preparations (suppositories, enemas, foams) that deliver medicine directly to the lower colon and rectum.

For mild to moderate UC, particularly when limited to the rectum or left side of the colon, 5-ASA medicines are typically the first-line treatment recommended by major guidelines. They are also commonly used long-term to maintain remission. A combination of oral and rectal 5-ASA is often more effective than either alone for left-sided disease.

Corticosteroids

Steroids such as prednisolone or budesonide MMX are used to bring active flares under control when 5-ASA medicines are not enough. They work quickly to reduce inflammation but are not suitable for long-term use because of side effects such as weight gain, raised blood sugar, mood changes, sleep disturbance, bone thinning and increased infection risk.

The general principle, supported by current guidelines, is that steroids should be used to bring a flare under control and then tapered off, with another medication taking over for maintenance. If you find yourself needing more than one course of steroids in a year, or unable to come off them without symptoms returning, your team will usually consider stepping up to a stronger maintenance treatment.

Immunomodulators

Medicines such as azathioprine, 6-mercaptopurine and, less commonly, methotrexate are used to dampen the immune response over the longer term. They take several weeks to months to start working, so they are not used to control a flare quickly but to maintain remission, often alongside or after steroids. Regular blood tests are needed to monitor for side effects on the bone marrow and liver.

Biologic therapies

Biologics are protein-based medicines given by injection or intravenous infusion that target specific parts of the immune system involved in UC. They have changed what is possible for people with moderate to severe disease. Several classes are used:

• Anti-TNF medicines such as infliximab, adalimumab and golimumab, which block tumour necrosis factor, a key inflammatory signal.
• Anti-integrin medicines such as vedolizumab, which act mainly in the gut and have a more selective effect on the immune system.
• Anti-interleukin medicines such as ustekinumab and mirikizumab, which target other inflammatory pathways.

Before starting a biologic, your team will usually screen for hidden infections such as tuberculosis and hepatitis B, because suppressing the immune system can reactivate these. Vaccination status is also reviewed.

Small-molecule oral medicines

Newer oral medications — including JAK inhibitors such as tofacitinib and upadacitinib, and sphingosine 1-phosphate receptor modulators such as ozanimod — have added more options for moderate to severe UC, especially when biologics have not worked or are not tolerated. These also require careful screening and monitoring.

Hospital treatment of severe flares

A severe flare that does not respond to oral treatment may need admission to hospital. Inpatient care typically includes intravenous steroids, intravenous fluids, treatment of anaemia, and close monitoring. If there is no improvement within a few days, rescue therapy with infliximab or ciclosporin is considered, and the surgical team is often involved in parallel in case an operation becomes necessary.

Surgery for ulcerative colitis

Surgery is not needed for most people with UC, but it is an important option when medical treatment fails to control the disease, when complications develop, or when there are changes in the bowel lining that raise the risk of cancer. Because UC affects only the colon and rectum, removing the colon (colectomy) effectively cures the bowel disease itself, although it does not affect symptoms outside the gut.

The most common operation today is a proctocolectomy with ileal pouch-anal anastomosis (IPAA), often called “pouch surgery”. The surgeon removes the colon and rectum and creates a new reservoir (pouch) from the end of the small intestine, connected to the anus, so bowel motions still pass through the natural route. This is usually done in two or three stages, with a temporary stoma in between.

In some situations — for example in older adults or where pouch surgery is not suitable — a permanent ileostomy may be the better option. Here the end of the small intestine is brought out through the abdominal wall and waste collects in a bag worn on the skin. Modern ostomy care allows most people to lead very full lives, including swimming, exercise and travel.

Decisions about surgery are made jointly with a colorectal surgeon and gastroenterologist. The right choice depends on disease severity, age, body shape, sphincter function, plans for pregnancy, and personal preference.

Lifestyle and Self-Management

Daily habits do not cause or cure UC, but they can influence how often flares happen and how well you feel between flares.

Food and nutrition

There is no single “UC diet” that works for everyone. Most gastroenterology societies advise a varied, balanced diet during remission rather than long lists of forbidden foods. However, food often plays a real role in symptoms, and the following patterns are commonly seen:

• During a flare, low-fibre and low-residue foods (white rice, well-cooked vegetables without skins, lean protein) are often easier to tolerate than raw vegetables, nuts, seeds and whole grains.
• Some people find that milk and other lactose-containing foods make symptoms worse, particularly during a flare.
• Highly spicy, very fatty or heavily processed foods are common triggers for symptoms in many people.
• Caffeine and alcohol can worsen diarrhoea and urgency for some.
• Carbonated drinks and certain sweeteners (such as sorbitol) can increase bloating and loose stool.

Keeping a simple food and symptom diary for a few weeks during and after a flare can help you and a dietitian identify your own pattern. Restrictive elimination diets without professional support are not generally recommended, as they can lead to nutritional deficiencies.

Nutritional deficiencies to watch

Ongoing inflammation, blood loss and reduced food intake during flares can lead to deficiencies. Your team may check and treat:

• Iron deficiency and iron-deficiency anaemia
• Vitamin B12 and folate
• Vitamin D and calcium, particularly if steroids have been used
• Protein and overall calorie intake during severe disease

Stress, sleep and mental health

Stress does not cause ulcerative colitis, but it can worsen symptoms and influence how flares are experienced. Anxiety and depression are more common in people with IBD than in the general population, partly because of the unpredictability of the disease and the impact on daily life. Sleep disturbance, in turn, can affect inflammation and energy levels.

Strategies that many people find helpful include regular physical activity, breathing or mindfulness practices, cognitive behavioural therapy (CBT) for those with significant anxiety or low mood, and structured support through patient organisations. If your mood is suffering, mentioning it to your gastroenterologist or family doctor is as important as describing your bowel symptoms.

Smoking, alcohol and recreational drugs

Stopping smoking is important for general health. NSAID painkillers such as ibuprofen and diclofenac can sometimes trigger flares, so paracetamol is usually preferred for general pain relief; check with your team before regularly using anti-inflammatory painkillers. Alcohol in moderation is generally tolerated during remission but can aggravate symptoms in some people.

Vaccinations and infection prevention

If you take immunosuppressive medicines, biologics or small-molecule agents, your risk of certain infections is higher and live vaccines may need to be avoided. Your team will review vaccinations including influenza, pneumococcal disease, hepatitis B, COVID-19 and others. It is usually best to update vaccines before starting strong immunosuppression where possible.

Monitoring and Long-Term Care

Ulcerative colitis is a long-term condition, and ongoing follow-up is part of keeping it well controlled.

Routine follow-up

• Regular reviews with a gastroenterologist, including symptom assessment and medication review
• Blood tests for inflammation, anaemia, liver and kidney function, and drug levels where relevant
• Faecal calprotectin tests to track inflammation between scopes
• Bone density assessment if steroids have been used for prolonged periods

Colon cancer surveillance

People with long-standing UC, particularly with extensive disease, have a higher risk of colon cancer than the general population. Major guidelines recommend starting surveillance colonoscopy about 8 to 10 years after diagnosis (or earlier in some situations, such as when UC occurs together with primary sclerosing cholangitis), and repeating it at intervals based on individual risk. The aim is to detect any pre-cancerous changes (dysplasia) early, when they can still be treated.

This is one of the reasons that maintenance treatment matters even when you feel well: keeping inflammation low over years also reduces the long-term cancer risk.

Complications

Most complications of UC can be prevented or managed with appropriate care. Awareness helps you and your team act early.

Complications related to disease activity

• Severe bleeding from ulcerated bowel lining
• Toxic megacolon — a rare but serious complication in which the colon becomes severely dilated and inflamed; this is a medical emergency
• Perforation of the bowel wall in severe disease
• Severe dehydration from prolonged diarrhoea

Longer-term complications

• Iron-deficiency anaemia and other nutritional deficiencies
• Bone thinning (osteopenia and osteoporosis), particularly with repeated steroid courses
• Higher risk of blood clots during flares
• Higher risk of colorectal cancer with long-standing extensive disease
• Primary sclerosing cholangitis (PSC), a liver disease that affects a small minority of people with UC

Living with Ulcerative Colitis

Beyond the medical details, much of what shapes life with UC is practical: how to plan a day, how to travel, how to talk about the condition at work, and how to manage the social side of an illness that is largely invisible.

Day-to-day strategies

• Know where the toilets are. Many people with UC plan journeys around access, especially during a flare. This is a normal and reasonable adjustment.
• Carry a small kit when out: spare underwear, wipes, a change of clothes during flares, and any rescue medication your team has agreed.
• Tell trusted people. Friends, family and a manager you trust can offer practical support if they understand what is happening.
• Pace activity. Energy levels often dip before bowel symptoms become obvious; respecting fatigue can help avoid a fuller flare.

Work and education

UC is a recognised long-term illness. Many people work full-time without significant disruption, particularly during remission. During flares, flexible hours, the ability to work from home, or short periods of leave may be needed. Open communication with a manager — without necessarily sharing all medical details — is usually more sustainable than concealment.

Pregnancy and family planning

Most people with UC can have healthy pregnancies. The general pattern, described by ECCO and other societies, is that disease activity at the time of conception strongly influences outcomes: conceiving during remission is safer for both parent and baby than conceiving during a flare. Pre-conception planning with your gastroenterologist is valuable.

Many UC medications are considered compatible with pregnancy and breastfeeding, but some are not, and the medication plan should be reviewed before pregnancy where possible rather than stopped abruptly when pregnancy is confirmed. Stopping treatment without medical guidance can trigger a flare, which is itself a risk to pregnancy.

Travel

Travel is generally possible during remission with some preparation:

• Carry medications in their original packaging with prescriptions and a doctor’s letter
• Carry more than you need, in case of travel delays
• Plan for time-zone changes with regular medication schedules
• Check vaccination requirements early, as some live vaccines may not be suitable if you are on immunosuppression
• Have an idea of who to contact for medical care at your destination

Ulcerative Colitis in Children

Although UC most often appears in adolescents and young adults, it can begin in childhood, and paediatric UC has some distinct features.

How paediatric UC differs

• Children are more likely than adults to have extensive disease at diagnosis, involving most of the colon.
• Growth, weight gain and pubertal development can be affected by chronic inflammation and by prolonged steroid use, so paediatric gastroenterologists try to minimise steroid exposure.
• School attendance, social development and mental health are central considerations in paediatric care.

Treatment in children

The medication classes used in children are broadly similar to those used in adults: 5-ASA medicines, steroids for flares, immunomodulators, and biologic therapies for moderate to severe disease. Dosing and monitoring are adapted to weight, age and growth. Surgical options are also similar, although the decision and timing are weighed especially carefully in young people.

Supporting a child with UC

• Work with the school to allow easy toilet access without drawing attention
• Plan for missed days during flares and how learning will be supported
• Watch for signs of low mood, anxiety or social withdrawal, which are common in children with chronic illness
• Encourage the child, as they grow, to gradually take responsibility for their own medication and appointments — the transition to adult care usually happens in the late teens

When to Seek Urgent Care

Between routine appointments, it is helpful to know what counts as an urgent change. Contact your gastroenterology team or attend an emergency department if you have:

• More than six bloody bowel motions a day, especially with fever or a fast heartbeat
• Severe abdominal pain or swelling
• Persistent vomiting or inability to keep fluids down
• Light-headedness, fainting or signs of significant blood loss
• A sudden, unexplained change after starting a new medication
• Signs of infection while on immunosuppressive treatment (fever, chills, persistent cough, painful urination)

Frequently Asked Questions

Is ulcerative colitis curable?

There is no medication that cures UC. However, long periods of remission are achievable for most people with current treatments, and surgery to remove the colon effectively eliminates the bowel disease itself, although it does not affect symptoms outside the gut.

Will I need surgery?

Most people with UC do not need surgery. Surgery is considered when medical treatment fails to control the disease, when complications develop, or when there are pre-cancerous changes in the colon. Decisions are made together with a gastroenterologist and a colorectal surgeon.

What is the difference between ulcerative colitis and Crohn’s disease?

Both are forms of inflammatory bowel disease. UC affects only the colon and rectum and only the innermost lining of the bowel, in a continuous pattern starting from the rectum. Crohn’s disease can affect any part of the digestive tract from mouth to anus, often in patchy areas, and can involve the full thickness of the bowel wall.

Can diet alone control my UC?

Diet plays an important supporting role, but it is not a substitute for medical treatment. Major society guidelines emphasise that food choices can help manage symptoms and maintain nutrition, while medications are needed to control the underlying inflammation.

Do I need to take medication when I feel well?

In most cases, yes. Maintenance treatment during remission is one of the most important factors in preventing flares and reducing long-term complications, including colon cancer risk. Stopping medication suddenly because you feel well is one of the common reasons flares come back.

Can I get pregnant with UC?

Yes. Most people with UC can have healthy pregnancies, particularly when the disease is in remission at the time of conception. Pre-conception planning with your gastroenterologist is valuable, especially to review medications.

Is stress causing my flares?

Stress does not cause UC, but it can worsen symptoms and is a recognised contributor to flares in some people. Managing stress is part of overall self-care but is not a replacement for medical treatment.

Will I need a stoma?

Only a minority of people with UC need a stoma, and when surgery is performed, modern techniques often allow the natural route for bowel motions to be preserved through pouch surgery. Where a stoma is needed, either temporarily or permanently, ostomy care today allows most people to continue work, exercise, travel and intimate relationships.

Does UC increase cancer risk?

Long-standing UC, particularly with extensive disease, is associated with a higher risk of colon cancer than the general population. Regular surveillance colonoscopy, usually starting 8 to 10 years after diagnosis, helps detect any pre-cancerous changes early. Good long-term control of inflammation also reduces this risk.

Conclusion

Ulcerative colitis is a long-term condition, but it is one that responds to careful, individualised management. The aims of care are to bring flares under control quickly, to keep the disease in remission for as long as possible, to heal the bowel lining, and to protect against complications over the years.

The most useful approach for most people combines steady medical treatment, attention to nutrition and lifestyle, regular monitoring, and an open relationship with a gastroenterology team that knows your history. With this combination, most people with UC live full lives — working, raising families, travelling and pursuing the activities that matter to them — even though the condition itself does not go away.